Work

Safety, feasibility and functionality of activated autologous dendritic cells for intratumoral injection in solid tumors: a Phase I clinical trial

Year: 2015

Type: conference-abstract

Abstract: Meeting abstracts Dendritic cells (DC) are proficient in initiating adaptive immune responses, through the uptake and subsequent presentation to the immune system of antigenic compounds. In preclinical studies, activated DC (aDC; DCVax®-Direct) were shown to be superior to immature DC in clearing

Source: Journal for ImmunoTherapy of Cancer

DOI: 10.1186/2051-1426-3-s2-p199

Authors: Vivek Subbiah, Ravi Murthy, David Hong, Robert Prins, Chitra Hosing, Robert Brown, McGuire Mary, Aung Naing, Siquing Fu, Anthony Conley, Indreshpaul Kaur, Kyle Hendricks, Deepthi Kolli, Lori Noffsinger, Marnix Bosch

Institutions: The University of Texas MD Anderson Cancer Center, University of California, Los Angeles, UCLA Health, The University of Texas Health Science Center at Houston, Northwest Biotherapeutics (United States)

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,490

OpenAlex ID: W2145790165

Cites:

Cited by:

Related to: 10